about
NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer modelsThe Drosophila forkhead transcription factor FOXO mediates the reduction in cell number associated with reduced insulin signalingCombining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the Hsp90 molecular chaperoneDiscovery and SAR of potent, orally available 2,8-diaryl-quinoxalines as a new class of JAK2 inhibitorsPotent and selective inhibition of polycythemia by the quinoxaline JAK2 inhibitor NVP-BSK805Modulation of Activation-Loop Phosphorylation by JAK Inhibitors Is Binding Mode Dependent
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Thomas Radimerski
@ast
Thomas Radimerski
@en
Thomas Radimerski
@es
Thomas Radimerski
@nl
Thomas Radimerski
@sl
type
label
Thomas Radimerski
@ast
Thomas Radimerski
@en
Thomas Radimerski
@es
Thomas Radimerski
@nl
Thomas Radimerski
@sl
prefLabel
Thomas Radimerski
@ast
Thomas Radimerski
@en
Thomas Radimerski
@es
Thomas Radimerski
@nl
Thomas Radimerski
@sl